SINGLE-DOSE, MULTIPLE-DOSE, AND THERAPEUTIC DRUG MONITORING PHARMACOKINETICS OF FIROCOXIB IN ASIAN ELEPHANTS (ELEPHAS MAXIMUS)
Journal of Zoo and Wildlife Medicine · 05.03.2024 · 55 (1) · 73-85
DOI: 10.1638/2022-0118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Zoo and Wildlife Medicine, erschienen am 05.03.2024. Verfasst von Jack Kottwitz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology Laboratory, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA, Kottwitz@MSU.edu. Hauptthemen laut MEDLINE: Elephants, Sulfones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Abstract (Originalsprache)
Firocoxib is a COX-2–selective nonsteroidal anti-inflammatory drug (NSAID) with limited effects on COX-1, which means it likely has fewer side effects than typically associated with other NSAIDs. This study determined possible doses of firocoxib based on single- and multidose pharmacokinetic trials conducted in 10 Asian elephants (Elephas maximus). Initially, two single oral dose trials (0.01 and 0.1 mg/kg) of a commercially available tablet (n = 6) and paste (n = 4) formulation were used to determine a preferred dose. The 0.1 mg/kg dose was further evaluated via IV single dose (n = 3) and oral multidose trials (tablets n = 6; paste n = 4). Serum peak and trough firocoxib concentrations were also evaluated in Asian elephants (n = 4) that had been being treated for a minimum of 90 consecutive days. Key pharmacokinetic parameters for the 0.1 mg/kg single-dose trials included mean peak serum concentrations of 49 ± 3.3 ng/ml for tablets and 62 ± 14.8 ng/ml for paste, area under the curve (AUC) of 1,332 ± 878 h*mg/ml for tablets and 1,455 ± 634 h*mg/ml for paste, and half-life (T1/2) of 34.3 ± 30.3 h for tablets and 19.9 ± 12.8 h for paste. After 8 d of dosing at 0.1 mg/kg every 24 h, pharmacokinetic parameters stabilized to an AUC of 6,341 ± 3,003 h*mg/ml for tablets and 5,613 ± 2,262 for paste, and T1/2 of 84.4 ± 32.2 h for tablets and 62.9 ± 2.3 h for paste. Serum COX inhibition was evaluated in vitro and ex vivo in untreated elephant plasma, where firocoxib demonstrated preferential inhibition of COX-2. No adverse effects from firocoxib administration were identified in this study. Results suggest administering firocoxib to Asian elephants at a dose of 0.1 mg/kg orally, using either tablet or paste formulations, every 24 h.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Pharmacology Laboratory, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA, Kottwitz@MSU.edu.
- University of Pennsylvania, School of Arts and Sciences, Philadelphia, PA 19104, USA.
- Clinical Pharmacology Laboratory, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA.
- Oregon State University, College of Pharmacy, Corvallis, OR 97331, USA.
Zitieren
APA
Kottwitz, J., Bechert, U., Cruz-Espindola, C., Christensen, J. M., & Boothe, D. (2024). SINGLE-DOSE, MULTIPLE-DOSE, AND THERAPEUTIC DRUG MONITORING PHARMACOKINETICS OF FIROCOXIB IN ASIAN ELEPHANTS (ELEPHAS MAXIMUS). Journal of Zoo and Wildlife Medicine, 55(1), 73-85. https://doi.org/10.1638/2022-0118
Vancouver
Kottwitz J, Bechert U, Cruz-Espindola C, Christensen JM, Boothe D. SINGLE-DOSE, MULTIPLE-DOSE, AND THERAPEUTIC DRUG MONITORING PHARMACOKINETICS OF FIROCOXIB IN ASIAN ELEPHANTS (ELEPHAS MAXIMUS). Journal of Zoo and Wildlife Medicine. 2024;55(1):73-85. doi:10.1638/2022-0118
BibTeX
@article{Kottwitz2024,
author = {Kottwitz, Jack and Bechert, Ursula and Cruz-Espindola, Crisanta and Christensen, J Mark and Boothe, Dawn},
title = {SINGLE-DOSE, MULTIPLE-DOSE, AND THERAPEUTIC DRUG MONITORING PHARMACOKINETICS OF FIROCOXIB IN ASIAN ELEPHANTS (ELEPHAS MAXIMUS)},
journal = {Journal of Zoo and Wildlife Medicine},
year = {2024},
volume = {55},
number = {1},
pages = {73--85},
doi = {10.1638/2022-0118}
}
EUVIMED